• Users Online:320
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 9  |  Issue : 3  |  Page : 193-199

Development of a new risk score for invasive cancer in branch-duct intraductal papillary mucinous neoplasms according to morphological characterization by EUS


1 Department of Gastroenterology, Complejo Hospitalario de Navarra, Pamplona, Spain
2 Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvaine, Brussels, Belgium; Department of Gastroenterology, Georges-Pompidou European Hospital, Paris, France
3 Department of Gastroenterology, Hospital Universitario de Santiago de Compostela, Santiago de Compostela, Santiago, Spain
4 Department of Gastroenterology, Hospital Universitario de Cruces, Bilbao, Spain

Correspondence Address:
Dr. Laura Uribarri-Gonzalez
Calle de Irunlarrea, 3, 31008 Pamplona, Navarra, Pamplona
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/eus.eus_11_20

Rights and Permissions

Background and Objective: The management of branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) is determined by a number of guidelines. The current weight of risk factors by EUS predicting invasive cancer is unknown. The aim of this study is to develop a risk score for early prediction of invasive cancer according to morphological characterization by EUS in a surgical cohort. Materials and Methods: This is an observational, multicenter retrospective study. All consecutive patients with a histologically proven BD-IPMN who underwent previous EUS between 2005 and 2017 were included. Morphological features by EUS were evaluated. A score using a logistic regression model was performed to assess the risk of invasive cancer. Results: Of 335 patients who underwent pancreatic surgery, 131 (median age: 66 years, 50.4% – male) were included. By multivariable analysis, lymph nodes (odds ratio [OR]: 17.7 [confidence interval (CI) 95%: 2.8–112.6], P = 0.002, 4 points), main pancreatic duct ≥10 mm (OR: 8.6 [CI 95%: 1.9–39.5], P = 0.006, 2 points), abrupt change of pancreatic duct (OR: 5.5 [CI 95%: 1.4–22.2], P = 0.016, 1.5 points), and solid component (OR: 4.2 [CI 95%: 1.3–13.6], P = 0.017, 1 point) were independent factors associated with invasive cancer and included in the model. The following categories of the score (0–8.5 points) – A (0–1), B (1.5–3), C (3.5–5), and D (5.5–8.5 points) – presented a positive predictive value of 8.5%, 38.9%, 62.5%, and 100%, respectively. The area under the curve was 0.857 (P < 0.001), with an overall sensitivity and specificity of 84% and 70% in the internal validation of the score. Conclusion: This EUS predictive score for invasive cancer in BD-IPMN has a high accuracy and could be an additional tool to consider in patient management.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed53    
    Printed0    
    Emailed0    
    PDF Downloaded23    
    Comments [Add]    

Recommend this journal